Cite

HARVARD Citation

    Song, X. et al. (2022). Clinical and prognostic implications of an immune‐related risk model based on TP53 status in lung adenocarcinoma. Journal of cellular and molecular medicine. 26 (2), pp. 436-448. [Online]. 
  
Back to record